Ocular Adverse Events Associated with Biologics Approved for Psoriasis: An FDA Adverse Event Reporting Database Study

被引：0
|
作者：
Katsiaunis, Apostolos [1 ]
Lipner, Shari R. [2 ]
机构：
[1] Tufts Univ, Sch Med, Boston, MA USA
[2] Weill Cornell Med, Dept Dermatol, 1305 York Ave, New York, NY 10021 USA
来源：
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY | 2025年 / 29卷 / 01期
关键词：
biologics; psoriasis; adverse effects; ocular;
D O I：
10.1177/12034754241293086
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：99 / 100
页数：2
相关论文
共 50 条
  • [1] Ocular adverse events of cenegermin used in neurotrophic keratopathy: an analysis of the FDA adverse event reporting system database
    Li, Yunfei
    Yang, Haiyun
    Gao, Yuan
    He, Weimin
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (03) : 385 - 391
  • [2] Assessing taxane-associated adverse events using the FDA adverse event reporting system database
    Lao, Dong-Hui
    Chen, Ye
    Fan, Jun
    Zhang, Jian-Zhong
    CHINESE MEDICAL JOURNAL, 2021, 134 (12) : 1471 - 1476
  • [3] Adverse events associated with carbamazepine: a pharmacovigilance study using the FDA Adverse Event Reporting System
    Huang, Shulan
    Dong, Hanlin
    Luo, Dongqiang
    Jiang, Jiazhen
    Liu, Manting
    Wu, Jiayu
    Dou, Xiangyun
    Zhou, Siyuan
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [4] Ocular adverse events associated with anti-VEGF therapy: A pharmacovigilance study of the FDA adverse event reporting system (FAERS)
    Ma, Pan
    Pan, Xinmei
    Liu, Ruixiang
    Qu, Ya
    Xie, Linli
    Xie, Jiangchuan
    Cao, Liya
    Chen, Yongchuan
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [5] Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
    Iarikov D.
    Wassel R.
    Farley J.
    Nambiar S.
    Infectious Diseases and Therapy, 2015, 4 (4) : 433 - 458
  • [6] Novel adverse events of blonanserin: a disproportionality analysis in the FDA Adverse Event Reporting System database
    Subeesh, Viswam
    Singh, Hemendra
    Maheswari, Eswaran
    Beulah, Thomas
    MINERVA PSICHIATRICA, 2018, 59 (02): : 105 - 110
  • [7] Alpelisib-related adverse events: The FDA Adverse Event Reporting System Database (FAERS) pharmacovigilance study
    Li, Yun
    Li, Hang
    Xiang, Zhongyuan
    HELIYON, 2024, 10 (06)
  • [8] Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
    Shu, Yamin
    He, Xucheng
    Wu, Pan
    Liu, Yanxin
    Ding, Yufeng
    Zhang, Qilin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [9] EXPLORING THE INCREASED SERIOUS ADVERSE EVENTS ASSOCIATED WITH INHALED TREPROSTINIL: AN FDA ADVERSE EVENT REPORTING SYSTEM DATABASE ANALYSIS
    Oli, Sharad
    Oli, Shital
    Niraula, Sristee
    Khanal, Resha
    CHEST, 2024, 166 (04) : 3535A - 3535A
  • [10] DRUGS ASSOCIATED WITH ADVERSE DRUG EVENTS IN CHILDREN: ANALYSIS OF THE UNITED STATES FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
    Lee, W. J.
    Schumock, G. T.
    Lee, T. A.
    VALUE IN HEALTH, 2013, 16 (03) : A70 - A70
12345